Timur Ivannikov
Stock Analyst at Raymond James
(0.40)
# 3,166
Out of 4,497 analysts
5
Total ratings
50%
Success rate
-26.14%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Downgrades: Market Perform | n/a | $33.70 | - | 1 | Jan 6, 2023 | |
| RCKT Rocket Pharmaceuticals | Initiates: Outperform | $22 | $22.82 | -3.59% | 1 | Jul 8, 2022 | |
| GOSS Gossamer Bio | Initiates: Outperform | $19 | $1.03 | +1,744.66% | 1 | Apr 18, 2022 | |
| APLS Apellis Pharmaceuticals | Maintains: Strong Buy | $112 → $114 | $37.98 | +200.16% | 1 | Mar 1, 2022 | |
| NEXI NexImmune | Initiates: Outperform | $750 | $1.91 | +39,167.02% | 1 | Apr 1, 2021 |
AnaptysBio
Jan 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $33.70
Upside: -
Rocket Pharmaceuticals
Jul 8, 2022
Initiates: Outperform
Price Target: $22
Current: $22.82
Upside: -3.59%
Gossamer Bio
Apr 18, 2022
Initiates: Outperform
Price Target: $19
Current: $1.03
Upside: +1,744.66%
Apellis Pharmaceuticals
Mar 1, 2022
Maintains: Strong Buy
Price Target: $112 → $114
Current: $37.98
Upside: +200.16%
NexImmune
Apr 1, 2021
Initiates: Outperform
Price Target: $750
Current: $1.91
Upside: +39,167.02%